BEIJING AIRDOC TECHNOLOGY CO., LTD. Financials Beijing Airdoc Technology Co., Ltd.
Equities
2251
CNE100004QQ9
Advanced Medical Equipment & Technology
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.56 HKD | +2.10% |
|
+11.44% | +36.86% |
| Apr. 17 | Beijing Airdoc Arm Setting Up 500 Million Yuan Fund | MT |
| Mar. 27 | Beijing Airdoc Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Capitalization 1 | 3,241 | 1,295 | 1,555 | 1,555 | - |
| Enterprise Value (EV) 1 | 1,445 | 34.97 | 1,139 | 605.6 | 605.6 |
| P/E ratio | -17.8 x | -7.15 x | -8.59 x | -55.6 x | 60 x |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | 28.1 x | 11.4 x | 5.58 x | 4.58 x | 2.87 x |
| EV / Revenue | 12.5 x | 0.31 x | 5.58 x | 1.78 x | 1.12 x |
| EV / EBITDA | -11.4 x | -0.22 x | -10 x | -25.2 x | 13.3 x |
| EV / FCF | -10.3 x | -0.09 x | -6.48 x | -6.8 x | -606 x |
| FCF Yield | -9.7% | -1,115% | -15.4% | -14.7% | -0.17% |
| Price to Book | 1.39 x | 0.77 x | 1 x | 1.03 x | 1.01 x |
| Nbr of stocks (in thousands) | 103,568 | 103,568 | 103,568 | 103,568 | - |
| Reference price 2 | 31.29 | 12.51 | 15.01 | 15.01 | 15.01 |
| Announcement Date | 3/17/22 | 3/23/23 | 3/27/24 | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Net sales 1 | 47.67 | 115.2 | 113.7 | 204 | 339.5 | 541 |
| EBITDA 1 | - | -126.7 | -159.6 | -113.4 | -24 | 45.5 |
| EBIT 1 | - | -142.2 | -182.3 | -145.3 | -40 | 25.5 |
| Operating Margin | - | -123.48% | -160.4% | -71.24% | -11.78% | 4.71% |
| Earnings before Tax (EBT) 1 | - | -142.5 | -182.7 | -145.9 | -34 | 31 |
| Net income 1 | - | -142.6 | -180 | -132.5 | -30.5 | 25.5 |
| Net margin | - | -123.83% | -158.37% | -64.98% | -8.98% | 4.71% |
| EPS 2 | -1.360 | -1.760 | -1.750 | -1.280 | -0.2700 | 0.2500 |
| Free Cash Flow 1 | - | -140.1 | -389.7 | -124 | -89 | -1 |
| FCF margin | - | -121.64% | -342.91% | -63.43% | -26.22% | -0.18% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 10/25/21 | 3/17/22 | 3/23/23 | 3/27/24 | - | - |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | - | 1,796 | 1,260 | 751 | 949 | 949 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | - | -140 | -390 | -124 | -89 | -1 |
| ROE (net income / shareholders' equity) | - | -12.8% | -10.3% | -6.75% | -2% | 1.7% |
| ROA (Net income/ Total Assets) | - | -12.2% | -9.91% | -7.9% | -2.4% | 1.3% |
| Assets 1 | - | 1,165 | 1,817 | 1,380 | 1,271 | 1,962 |
| Book Value Per Share 2 | - | 22.50 | 16.20 | 15.00 | 14.60 | 14.80 |
| Cash Flow per Share 2 | - | -1.390 | -3.690 | -0.8100 | -0.3200 | 0.2300 |
| Capex 1 | - | 28 | 9.3 | 13 | 18.5 | 40 |
| Capex / Sales | - | 24.31% | 8.18% | 6.65% | 5.45% | 7.39% |
| Announcement Date | 10/25/21 | 3/17/22 | 3/23/23 | 3/27/24 | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
15.01
CNY
Average target price
18.69
CNY
Spread / Average Target
+24.52%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +36.86% | 215M | |
| +3.31% | 32.09B | |
| +15.77% | 7.56B | |
| +21.60% | 3.85B | |
| -17.44% | 3.18B | |
| -27.80% | 1.23B | |
| -31.01% | 1.17B | |
| -34.81% | 911M | |
| +3.51% | 906M | |
| -25.45% | 860M |
- Stock Market
- Equities
- 2251 Stock
- Financials Beijing Airdoc Technology Co., Ltd.
